ArticleScientific reports2025
Efficacy, psychological and physical adverse effects of isotretinoin in the treatment of acne: a cross-sectional study from Syria.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to evaluate the effectiveness of isotretinoin in the treatment of acne, while also monitoring its associated physical and psychological adverse effects. A descriptive cross-sectional study was conducted using an online questionnaire distributed to individuals who are currently experiencing acne or have experienced it in the past. The questionnaire included items regarding acne severity, type and duration of treatment, adherence, side effects and overall satisfaction. Data were statistically analyzed. A total of 377 participants, aged ≥ 15 years, were included in the study. 89.1% of them followed isotretinoin treatment, of whom 316 found an overall improvement (262 as marked). Side effects were experienced by 309 with most commonly reported ones were physical (supplementary Table 1). 189 (56.3% of isotretinoin users) reported psychological symptoms such as anxiety, mood changes, depression or even suicidal thoughts. Despite side effects, 86.2% were satisfied with the treatment's efficacy, while 19.9% discontinued the medication due to adverse effects. Isotretinoin is widely regarded as an effective treatment for moderate to severe acne. However, its use requires strict medical supervision before and during the treatment period due to its wide range of potential physical and psychological adverse effects. The findings underscore the critical importance of comprehensive awareness among patients, physicians and pharmacists regarding the potential risks-particularly psychological ones-that may escalate to suicidal tendencies in vulnerable individuals. This highlights the necessity for integrated management approaches that include regular medical and psychological monitoring. Given the persistent neglect of mental health in many communities, especially low-income countries, these results are concerning and call for increased public awareness and a shared responsibility among healthcare providers and patients. Healthcare providers should inform patients (and parents if possible) about such adverse effects and encourage them to immediately report any concerning symptoms so that the most suitable decision can be made, including discontinuation of the drug and referring to psychologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.